Form 4: Oncology Institute's Chief Medical Officer, Yale Podnos, Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Yale Podnos, Chief Medical Officer of Oncology Institute, Inc., sold 1,801 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On May 21, 2025, Yale Podnos, the Chief Medical Officer of Oncology Institute, Inc. (TOI), disposed of 1,801 shares of common stock.
- The transaction was executed at a price of $2.675 per share.
- The sale was conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Podnos directly owns 234,336 shares of Oncology Institute, Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes on vested RSUs), so the sentiment is neutral.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Stakeholder Impact
- The sale of shares by a company executive could have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of transaction: Yale Podnos disposed of 1,801 shares of common stock. |
| 05/22/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Oncology Institute, Yale Podnos, Chief Medical Officer, Stock Sale, RSU, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.